BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Swedish Orphan Biovitrum 

SE-112

  76  Stockholm  Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Swedish Orphan Biovitrum Publishes Annual Report 2013 4/16/2014 9:49:49 AM    More...
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014 8:47:16 AM    More...
Notice Of Annual General Meeting In Swedish Orphan Biovitrum 4/3/2014 8:27:13 AM    More...
TiGenix : Licenses Exclusive Marketing And Distribution Rights For Chondrocelect To Swedish Orphan Biovitrum 4/3/2014 8:13:40 AM    More...
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014 10:48:14 AM    More...
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014 9:56:15 AM    More...
Health Canada Approves Swedish Orphan Biovitrum's Alprolix™ 3/21/2014 8:32:51 AM    More...
Swedish Orphan Biovitrum Publishes Its Report For The Fourth Quarter And Full Year 2013 2/20/2014 9:12:26 AM    More...
Swedish Orphan Biovitrum To Temporarily Withdraw New Drug Application For Orfadin® Oral Suspension In The US 12/27/2013 7:24:27 AM    More...
Swedish Orphan Biovitrum To Take Direct Responsibility For Orfadin In The US, Canada And Latin America 12/20/2013 10:00:21 AM    More...
12345

//-->